Rapid improvement in severe lupus glomerular lesions following intensive plasma exchange associated with immunosuppression.
D000293:Adolescent; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008181:Lupus Nephritis / Q000628:therapy*; D010951:Plasma Exchange
D007166:Immunosuppressive Agents